Indian govt changes its mind: Passports to retain address page; Orange plan dropped

News Network
January 31, 2018

The Union government of India has taken a U-turn on its controversial decision to change the colour and format of the passports. Yes, your passports will retain the last the page with your address and other personal details. Moreover, the government also has dropped plans to introduce orange-coloured passports.

The foreign ministry on Tuesday said that it had been decided to continue with the current practice of printing the last page of the passport and not to issue a separate passport with an orange coloured jacket to ECR (Emigration Clearance Required) passport holders.

The orange passport that was proposed earlier would be used by citizens who have not passed their class 10 examination. It was also supposed to protect against worker exploitation overseas. The proposal was met with criticism especially from Congress president Rahul Gandhi who claimed that the orange and blue colour schemes could lead to discrimination.

The ECR category is for passport applicants who haven't finished school. They are primarily used to secure employment in 18 countries around the globe.

Comments

Well Wisher
 - 
Wednesday, 31 Jan 2018

ಕೆಲಸವಿಲ್ಲದ ಬಡಗಿ ತನ್ನ ..... ..... ಕೆತ್ತಿದಂತೆ

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 28,2020

Bengaluru, Mar 28: Sun Tsu, in 'The Art of War' speaks of a skilful general who can subdue his enemy without any fighting. This constitutes the ultimate triumph which is referred to as stratagem. Today, we would need one such when we are faced with the '21-day corona challenge' for India.
Nearly four weeks back, Dr Jyothsna Rao, Dr Gururaj Rao and I sat across the OPD in the afternoon at HCG Bengaluru discussing our ongoing cancer immunology research. While on this topic, we drifted into the discussion on the coronavirus. During this engaging discussion, we wondered the similarity of the enigma between the virus and cancer. I paused to ask Dr Jyothsna and Dr Guru - how we wish we could do something against this virus.
Dr Jyothsna is a PhD from NCBS and had worked under Dr Ralph Steinman, physician and researcher from Rockefeller University, who won the Nobel Prize for his discovery of the dendritic cell and its role in adaptive immunity in 2011. Dr Gururaj is a molecular and cell biologist who did his PhD at the Chapel Hill, University of North Carolina and is the Director of iCrest.
Jyothsna while hearing our perplexing conversation on the covid intervened, "Yes, surely. I think we should take a break from cancer and focus on the innate and adaptive immunity role in COVID-19."
Thus began this sincere attempt to relook the human immune system from the eyes of the COVID-19.
We have 10 types of immune cells at the least which are widely dispersed in millions across the body. When our body is invaded by a foreign organism (bacteria, fungi or virus), these cells work with each other to destroy the invader.
Now, the question is - how do the immune cells talk to each other? They use small-molecule substances called cytokines (cyto means cells; kine means movement). There are many cytokines that are involved in work on the immune system. The most relevant for viruses are interferons.
Interferons (IFN) as the name reflects have an ability to interfere with the viral activity and stop their multiplication. These specialised signal proteins are released by our cells in response to a viral attack to forewarn other cells. They help build the antiviral proteins within the cells to kill the virus as it tries to invade the new cells.
Historically, interferons are a group of cytokines known to be potent antiviral agents against viruses and a hallmark cytokine induced by the host upon viral infections. Interferons possess unique immunoregulatory activities and are signature cytokines released by (TH1) T immune cells, which are crucial in viral infections.
As the outbreak of COVID-19 grapples us, an urgent need for finding strategies to combat the virus is growing. Coronaviruses (CoVs) are a group of RNA viruses. In patients infected with coronavirus, it was indicated that the activation of the IFN does not occur until 48 hours post-infection. Thus the delayed IFN-related antiviral response by the healthy cells leads to coronavirus evade the immune response.
Numerous studies have presented the success in defeating CoVs by the direct administration of IFNs. In a combination as a concoction, it was shown to synergistically inhibit the virus replication in vitro.
Moreover, it is understood that the earlier induction of IFNs in children although they have a less developed immune system could be the reason behind the children being least affected.
The key to success in reducing the disease fatality might be the stimulation of the immune responses to trigger IFN production at the very early stages of the disease, which might be done through the administration of IFN. Despite the evidence for the efficacy of IFNs in treating CoV-induced infections, the proper dosing and ideal timing for such interventions needs to be verified in clinical trials.
For the later stages of the diseases in advance stages where patients are on ventilator and have developed respiratory distress, we propose to utilise the mesenchymal cells derived from donor bone marrow that have been known to treat acute respiratory syndrome. Mesenchymal cells are known to possess anti-inflammatory activity and thus used often in autoimmune diseases.
With this scientific background, we have activated T cells from healthy donors, in a cGMP facility at iCrest - HCG hospital with an enriched cocktail of cytokines rich in Interferons. Injections of this cocktail we believe will result in a surge of cytokines in the body of the infected person and will boost his ability to fight the virus in the early phases. We are in the initial phases of this study and hope to be ready in the coming weeks with meaningful data on its potential utility.
Currently, it awaits government approvals (Union and state) and we have applied to central drugs authority for their initial evaluation and further directions.
As my Guru often expounded the philosophy of 'Seva' - the goal of education is knowledge, the end goal of knowledge is service. In this attempt to serve our fellow humans at this brink of unprecedented crisis, medical fraternity stands with you and promises to do our best for your safety.
We assure to exhaust every bit of our spirit in this fight against coronavirus. We have lost the sight of shores and travelled thus far, but that is the mandatory first step to cross the ocean. Are we going to succeed in this battle, is something only time will answer. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 5,2020

Mangaluru, Mar 5: Chairman of Karnataka Christian Development Committee (CDC) Joylus DSouza on Thursday welcomed the allocation of a Rs 200-crore grant in the state budget for the development of the Christian community.

In his message to the Chief Minister B S Yediyurappa released to the media, DSouza said, "Christians in Karnataka welcome with gratitude the announcement of Rs 200-crore allocation for the community in the budget for fiscal 2020-21."

In 2011-12 fiscal also, Yediyurappa as Chief Minister had allocated a grant of Rs 50 crore for the community for the first time in the history of the state, he said.

The grant of Rs 200 crore this year shows Yediyurappas concern for the Christians.

I congratulate and offer my sincere gratitude on behalf of the Christian community of the state to Yediyurappa, DSouza said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 30,2020

Bengaluru, Jul 30: As the protest by Accredited Social Health Activist (ASHA) workers entered the 20th day, Karnataka Health Minister B Sriramulu on Wednesday assured them that he would take up their demands with Chief Minister B S Yediyurappa.

The ASHA workers are sitting in protests with a number of demands that include a minimum salary of Rs 12,000 per month.

Assuring that their matter will be taken up, Karnataka Health Minister B Sriramulu said while speaking to reporters, "We know how hard ASHA workers have been working as frontline warriors in the fight against COVID-19. I will discuss with CM about their demand for a minimum wage of Rs 12,000 per month and the final decision will be taken soon."

"We went to the police to allow us to protest. Officials then took us to the CM. During the meeting, he demanded some time to sort out our issues. 

We told him we are protesting for the past 20 days and that it was he who needs to call a meeting with us. Only then will he know the problems being faced by ASHA workers," an ASHA worker said clad in her signature pink sari.

"When asked as to why salaries of ASHA workers were not hiked, while it was done for doctors and other healthcare officials, the CM requested for time to look into the matter. 

We are not much happy now, but will if he comes in front of the media and promises to sort out our issues, then we will listen to him", she added.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.